Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: Implications for combination TKI therapy

Research output: Contribution to journalLetter

23 Citations (Scopus)
LanguageEnglish
Pages658-660
Number of pages3
JournalLeukemia
Volume24
Issue number3
DOIs
Publication statusPublished - 1 Jan 2010

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

@article{2559d3f2096d43378846e806744bd79a,
title = "Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: Implications for combination TKI therapy",
author = "Hiwase, {D. K.} and D. White and S. Zrim and V. Saunders and Melo, {J. V.} and Hughes, {T. P.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1038/leu.2009.242",
language = "English",
volume = "24",
pages = "658--660",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells

T2 - Leukemia

AU - Hiwase, D. K.

AU - White, D.

AU - Zrim, S.

AU - Saunders, V.

AU - Melo, J. V.

AU - Hughes, T. P.

PY - 2010/1/1

Y1 - 2010/1/1

UR - http://www.scopus.com/inward/record.url?scp=77949424637&partnerID=8YFLogxK

U2 - 10.1038/leu.2009.242

DO - 10.1038/leu.2009.242

M3 - Letter

VL - 24

SP - 658

EP - 660

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -